Lacey DL et al. |
Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo. |
2000 |
Am. J. Pathol. |
pmid:10934148
|
Quinn JM et al. |
Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation. |
2000 |
J. Bone Miner. Res. |
pmid:10934644
|
Min H et al. |
Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis. |
2000 |
J. Exp. Med. |
pmid:10952716
|
Shiba H et al. |
Effects of ageing on proliferative ability, and the expressions of secreted protein, acidic and rich in cysteine (SPARC) and osteoprotegerin (osteoclastogenesis inhibitory factor) in cultures of human periodontal ligament cells. |
2000 |
Mech. Ageing Dev. |
pmid:10958924
|
López FJ |
New approaches to the treatment of osteoporosis. |
2000 |
Curr Opin Chem Biol |
pmid:10959765
|
Udagawa N et al. |
Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function. |
2000 |
Endocrinology |
pmid:10965921
|
Yasuda H |
[A new paradigm of osteoclast biology: discovery of OCIF and ODF]. |
2000 |
Seikagaku |
pmid:10967683
|
Teitelbaum SL |
Bone resorption by osteoclasts. |
2000 |
Science |
pmid:10968780
|
Nakashima T et al. |
Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines. |
2000 |
Biochem. Biophys. Res. Commun. |
pmid:10973797
|
Itoh K et al. |
Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors. |
2000 |
J. Bone Miner. Res. |
pmid:10976996
|